Thrombotech to begin Phase I trial of stroke treatment
 

Thrombotech to begin Phase I trial of stroke treatment

Rishon Le Zion : Israel | Feb 04, 2010 at 5:40 AM PST
Source: Globes Online
0 1
Views: 28
 
Thrombotech Technologies Ltd. has obtained Ministry of Health approval to begin a Phase I human clinical trial of its stroke treatment, a peptide, THR-18, which is administered alongside existing stroke treatments. The trial will include 40 healthy volunteers to test the safety of THR-18 to enable... FULL ARTICLE AT Globes Online
 
 
 
Advertisement
 
Advertisement
 
 
Tap_logo_330_103
Local to Global News
 
 Connect 
Sign up now!

Sitemap


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2012. All rights reserved.